Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CRSP compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
CRSP
CRISPR Therapeutics AG
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
CRSP
CRISPR Therapeutics AG
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
CRSP
CRISPR Therapeutics AG
Change
49.98
▼
−2.80%
· post 49.90
· delayed
Mkt cap
$5.0B
Revenue
$13M
Q3 FY26
Revenue
$4M
FY25
AMGN
Amgen Inc
Change
465.45
▼
−0.12%
· post 467.60
· delayed
After hours
Nov 2 '26
delayed
Mkt cap
$251.9B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
vs
Compare
After hours
Nov 2 '26
delayed
CRSP
CRISPR Therapeutics AG
vs
AMGN
Amgen Inc
49.98
▼
−2.80%
post 49.90
delayed
Price
465.45
▼
−0.12%
post 467.60
delayed
$5.0B
Mkt cap
$251.9B
Q3 FY26
$13M
Revenue
$10.1B
Q2 FY26
FY25
$4M
Revenue
$36.8B
FY25
Change
Change
CRSP
49.98
▼
−2.80%
vs
AMGN
465.45
▼
−0.12%
After hours
Nov 2 '26
delayed
Earnings history
last 4 reports each · paired by recency
Method
›
CRSP
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±7.8%
▲
+7.06%
×0.91
Q1 FY26
±5.9%
▼
−2.24%
×0.37
Feb 13 '26
±3.6%
▲
+8.46%
×2.36
Q3 FY25
±8.4%
▼
−0.98%
×0.12
AMGN
4 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±4.1%
▲
+4.57%
×1.12
Q1 FY26
±3.9%
▼
−4.75%
×1.23
= implied
CRSP realized, solid
AMGN realized, hatched
One scale, both sides: full bar = 9%
× = |realized| ÷ implied
Source: market data
Feb 4 '26
±3.7%
▲
+8.15%
×2.22
Q3 FY25
±3.7%
▲
+7.81%
×2.11